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Background: Malignant perivascular epitheliod cell tumor (PEComa) is a very rare entity composed of distinctive
perivascular epitheliod cells with variable immunoreactivity for melanocytic and muscle markers. At present this
neoplasm does not have a known normal cellular counterpart and the natural history is often unpredictable. Up to
now, few cases of PEComa have been described and treatment modalities are still controversial, particularly in
advanced conditions.
Case presentation: We handled the case of a 42-year-old man with unresectable PEComa of the abdomen. A 7
cm hepatic hypodense lesion between segment V and VIII of the liver and diffuse intraperitoneal nodules of 0,3-3,5
cm along the right subcapsular hepatic region, were documented by a CT scan. Radiological images showed
abnormal lymph nodes of the right internal mammary chain and anterior mediastinum. The patient underwent an
explorative laparotomy for uncontrolled intrabdominal hemorrhage without a well-defined preoperative tumor
diagnosis. At surgery, multiple lobulated nodules containing hemorrhagic fluid on the liver surface, peritoneum and
omentum were confirmed. The procedure had a palliative intent and consisted of hemostasis, hematomas
evacuation and omentectomy. The diagnosis of PEComa was made after surgery on the basis of morphological
and immunohystochemical criteria. Radiological and intra operative findings suggest that the mass has an hepatic
origin with diffuse involvement of hepatic capsule and suspensory ligaments. The patient received medical support
care with blood and plasma transfusions. In our experience, PEComa was clinically malignant, leading to a fatal
outcome 25 days after hospital admission of patient.
Conclusions: Here we report and discuss the peculiar clinical, radiological and morphological presentation of
unresectable PEComa. Although in the majority of the reported series, PEComas show a more better prognosis, our
case presents with a particular aggressive biological behaviour. The importance of a correct preoperative diagnosis,
the need for more effective targeted therapies based on tumor molecular knowledge and evidence-based clinical
studies are emphasized together with a revision of the concerning scientific literature.
Background
PEComa is a mesenchimal neoplasm, predominantly
affecting young adults and female individuals [1]. It
includes clear cell “sugar” tumor of the lung and extra-
pulmunary sites, angiomyolipoma, clear cell myomelano-
cytic tumor of the falciform ligament/ligamentum teres
and rare lymphangioleiomyomatosis-like tumors [2].
PEComa has been identified at multiple anatomic sites,
such as the liver, uterus, vulva, rectum, heart, breast,
urinary bladder, abdominal wall and pancreas, and has
been associated with few, if any symptoms, though
abdominal pain and bleeding have been reported [1-4].
Preoperative differential diagnosis includes gastrointest-
inal stromal tumors, melanoma, clear cell sarcoma, leio-
myosarcoma [5]. A well-defined preoperative diagnosis
is hard to make because of non-specific radiological fea-
tures [1]. Preoperative biopsy might overcome this lim-
itation, but the data coming from current clinical
practices suggest that PEComa diagnosis is usually con-
firmed after surgery [1,3]. The biological behaviour of
PEComa varied in different cases, some of which devel-
oped metastasis, local recurrence or death [6]. We
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a young man who underwent an exploratory laparotomy
for uncontrolled intrabdominal hemorrhage.
Case presentation
A 42-year-old male was admitted to our observation
with dyspnea, temperature, abdominal discomfort and
weight loss. He had previously experienced tuberculosis
infection, and his past surgical history was uneventful.
The physical examination confirmed epigastric and
mesogastric pain. The radiological images demonstrated
right fluid pleurical collection with passive collapse of
the lung inferior lobe, abnormal lymph nodes of the
right internal mammary chain and anterior mediastinum
(Figure 1). At the patient admission, we had drained the
right symptomatic hemothorax and sent to our patholo-
gists the pleurical fluid for cytology exam. The patient
underwent an abdominal CT scan that demonstrated a
7 cm hypodense lesion between segment V and VIII of
the liver with minute calcifications, inhomogeneously
hypoattenuating relative to the surrounding liver par-
enchyma. This lesion was surrounded by a very thin
capsule showing irregular limits in the cranial portion.
The right hepatic lobe showed irregular profile with the
presence of diffuse lesions of 0,5-3,5 cm in length,
reported along right triangular ligament and subcapsular
hepatic region, suspected for hematomas. Hemoperito-
neum was also documented (Figure 1). According to the
severe clinical condition and the hemodynamic instabil-
ity, the patient underwent hepatic angiography with
selective catheterization of the common hepatic artery,
its branches and right diaphragmatic artery. The diag-
nostic phase of angiography did not document any
active bleeding, as well as during the selective coaxial
study of the intrahepatic arterial branches of right hemi-
system and right diaphragmatic artery. An exploratory
laparotomy was finally proposed. At surgery, the hepatic
mass, the multiple subcapsular hematomas, and the
hemoperitoneum were confirmed (Figure 2). The liver
had no signs of cirrhosis. The extemporaneous biopsy
showed signs of undifferentiated carcinoma. The surgi-
cal procedure consisted in omentectomy, toilette and
hemostasis of the peritoneal cavity.
The histological diagnosis of malignant PEComa is
based on the published criteria by Folpe and co-workers.
In our case, the tumor is characterized by the prolifera-
tion of epitheliod and spindle cells. The neoplastic cells
are arranged in small-nests or sheet-like patterns, tra-
versed by a delicate vasculature consisting of a rich net-
work of sinusoid-type blood vessels. The tumor cells
showed a round to oval nucleus, often with prominent
nucleolus and exhibited high nuclear pleomorphism.
The tumor is comprised of a population of large poly-
clonal cells with abundant cytoplasm. The mitotic index
is elevated (> 40 figures per 50 high power fields, HPF)
and the coagulative necrosis, a prominent feature,
appeared as multiple foci of variable sizes. Microscopi-
cally the tumor border was infiltrative.
For immunohistochemistry on formalin-fixed paraffin-
embedded samples, sections were treated with H2O2/3%
for 5 minutes to inhibit endogenous peroxidase and
then washed in H2O. Antigen was unmasked by treat-
ment with EDTA at pH 9, or with citrate buffer at pH 6
in a microwave oven (two 5-minutes courses). The slices
were then held for 20 minutes at room temperature.
After washing in PBS/Tween-20, sections were
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Figure 1 CT appearance of PEComa: axial (a), coronal (b) and sagittal (c) reconstructions. CT of the abdomen showed a 7 cm lesion in
the right lobe of the liver with multiple ovular lesions of 0.5-3.5 cm along right triangular ligament, hypoattenuating relative to the surrounding
hepatic tissue with minute calcifications. Hypodense lesions along right triangular ligament and capsular profile of falciform ligament were
additionally documented. In the thorax CT images, abnormal lymph nodes of 2,8 cm in length were observed along internal right mammary
chain, anterior mediastinum and aorta-lung interface. Multiple nodular lesions of the lung were documented in the right hemi-thorax.
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Then, they were washed and stained with Bond™ Poly-
mer Refine/HRP Detection Kit according to the manufac-
turer’s protocol (Leica, Wetzlar, Germany) or Bond™
Polymer Refine Red Detection Kit (Leica) for HMB-45 an
Melan-A. For negative controls, we substituted non-
immune sera for the primary antibodies. The immuno-
histochemistry analysis demonstrated positive staining
for Vimentin (Novocastra), Melan-A (Dako), HMB-45
(Dako), smooth muscle actin (SMA) (Dako), MIB-1
(Novocastra), and CD31 (Novocastra). It was negative for
S-100 protein (Dako), Cytokeratin-AE1/AE3 (CKAE1/
AE3) (Novocastra), Cytokeratin-5 (CK5) (Novocastra),
CD30 (Dako). Based on this specific immunophenotype
profile, diagnosis of PEComa was made (Figure 3-4). The
multiple lesions, suspected to be lymphatic metastasis in
the thorax CT images, were not confirmed by a cytology
exam of pleurical fluid. Infact, the cytology analysis has
documented the presence of leucocytes, red globular cells
and rare mesothelial cells, but not tumor cells. It was
impossible in our case to confirm histologically the
suspected metastatic lesions observed along lymphatic
internal right mammary chain, anterior mediastinum,
aorta-lung interface and of the lung.
The immediate post-operative course was uneventful
and the patient received supporting therapy with blood
and plasma transfusions. PEComa was clinically malig-
nant, leading to a fatal outcome in our experience.
Discussion and Conclusions
In 1992, Bonetti proposed the concept of perivascular
ephiteliod cells (PECs) and the term PEComa was first
introduced by Zamboni four years later [3]. Only in
2003, after the initial scepticism, the World Health
Organization defined PEComas as mesenchymal tumors
[7]. One current hypothesis is that the neoplasm derives
from undifferentiated cells of the neural crest with
smooth muscle and melanocytic phenotype. A second
hypothesis is that PEC has a myoblastic, smooth muscle
origin. A third concerns the perycitic origin [4]. PECo-
mas have been described in different organs and are
considered ubiquitous tumors. Clinical presentation is
not specific and a correct pre-operative diagnosis is dif-
ficult to make. It might be often misdiagnosed with
hepatocellular carcinoma, hemangioma, focal nodular
hyperplasia and GIST tumor [5]. CT scan is uninforma-
tive regarding the tumor nature. Histology with immu-
nohistochemistry techniques are needed to make the
correct diagnosis [5-7]. Usually, the diagnosis of
PEComa is confirmed after surgery, as reported by the
current clinical practice [1,3]. About 100 PEComas has
been reported, of which 38 involved the uterus [8].
Recently, Folpe and colleagues have suggested criteria
for malignancy, including a size greater than 5 cm,
mitotic count of more than 1 per 50 high-power fields
and necrosis [7]. These criteria were observed in our
clinical case. PEComa showed hypercellularity, hyper-
chromasia, high mitotic activity, atypical mitotic figures
and coagulative necrosis. We have documented a strong
and diffuse reactivity for melanocytic markers, such as
HMB-45 and Melan-A, in the cytoplasm of tumor cells
together with a focal positivity for SMA. In addition, we
have documented a CD34 positive staining of the capil-
lary network surrounding the tumor cells. Depending on
b
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Figure 2 Intraoperative appearance of PEComa. Multiple lobulated nodules containing hemorrhagic fluid on the hepatic capsule, peritoneum
surface (a) and omentum (b) associated with hemoperitoneum were observed. The surgical procedure consisted in toilette of peritoneal cavity,
omentectomy and hemostasis. In our case, it was impossible to perform an oncological curative surgery.
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Figure 3 Histological and immunohistochemical profile of PECs. Tumor cells showed severe atypia, cytological pleomorphism, high mitotic
activity and atypical mitotic figures (Hematoxylin-Eosin, x40)(a). Both epithelioid and spindle cells were diffusely positive for HMB-45 (x200)(b)
and Melan-A (x63)(c) antigens in the cytoplasm. The prominent capillary network, but not tumor cells, showed CD34 positive staining (x40)(d).
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Figure 4 Histological and immunohistochemical profile of PECs. Tumor cells showed marked coagulative necrosis (Hematoxylin-Eosin, x40)
(a). In PECs, SMA had a focally cytoplasmic positivity (x40)(b). Nuclear MIB-1 reactivity was documented in PECs (x200)(c). We observed a strong
and diffuse membrane reactivity for CD31 in tumor cells (x40)(d). The tumor was negative for all other markers mentioned, including S-100,
CKAE1/AE3, CK5, CD30.
Selvaggi et al. BMC Surgery 2011, 11:3
http://www.biomedcentral.com/1471-2482/11/3
Page 4 of 5specific microenvironment locations, PECs can modulate
their morphology and immunophenotype. In some con-
ditions, PECs can pronounce muscle features and in
others they can exhibit more epithelioid morphology
with strong positivity for HMB45 and weak or focal
expression for SMA, as in our condition. On the basis
of these peculiarities, the diagnosis of malignant
PEComa was made. Interestingly, we have documented
CD31 positivity in the cellular membrane of PECs. This
result is not so unusual, because other reports have
documented the reactivity of CD31 marker in a subset
of malignant PEComa, termed PEComas not otherwise-
specified [8]. PEComa of the liver is extremely unusual
and only a few cases have been reported to date. To the
best of our knowledge, there are less than 10 reported
cases of liver PEComas [9]. The right lobe of the liver is
the most common site and all cases occurred adjacent
to the ligamentum teres and falciform ligament [1]. Sur-
gical resection represents the only curative approach for
primary PEComa at presentation as well as for local
recurrences and metastasis, as chemotherapy and radio-
therapy have not demonstrated significant benefits
[8,10]. Only recently limited clinical studies have
reported encouraging results in terms of therapeutic
response after oral administration of mTOR inhibitor in
patients with metastatic PEComa [11]. Our case repre-
sents the clinical condition of malignant PEComa of the
liver presented with intrabdominal metastases. Radiolo-
gical pattern and intraoperative founding suggest that
the mass has an hepatic origin with diffuse involvement
of hepatic capsule and suspensory ligaments. Although
the majority of clinical reports on PEComa shows a bet-
ter outcome, our case highlights the aggressive biologi-
cal nature of a malignant subset of PEComa
characterized by an infaust evolution.
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